Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"Improving postnatal maternity care following severe perineal trauma by evaluating end-user's experiences of a pilot trial exploring laxative management; A qualitative study".

Applied nursing research : ANR·2025
Same author

Prognostic factors in bushfire-affected koalas-Kangaroo Island bushfire response 2020.

Australian veterinary journal·2025
Same author

Anaesthetic management of people with multiple sclerosis.

Multiple sclerosis and related disorders·2023
Same author

Enhancing diabetes care for the most vulnerable in the 21st century: Interim findings of the National Advisory Panel on Care Home Diabetes (NAPCHD).

Diabetic medicine : a journal of the British Diabetic Association·2023
Same author

Role of four-dimensional computer tomography (4D-CT) in non-localising and discordant first-line imaging in primary hyperparathyroidism.

Annals of the Royal College of Surgeons of England·2023
Same author

Can Real-world Data and Rapid Learning Drive Improvements in Lung Cancer Survival? The RAPID-RT Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same journal

Procalcitonin use in Acute Medicine in the United Kingdom: a survey of practice, barriers and facilitators.

Acute medicine·2026
Same journal

What does a job in Acute Medicine look like? Insights from the RCP 2023 Workforce Census.

Acute medicine·2026
Same journal

Embedding penicillin de-labelling in the AMU: a feasibility and safety pilot study with exploratory economic and environmental analysis.

Acute medicine·2026
Same journal

'Not All Swellings Are Angioedema' - An Overview And Systematic Approach For Acute Medical Physicians.

Acute medicine·2026
Same journal

The experiences of international medical graduates (IMGs) new to the NHS: an interpretive phenomenological analysis.

Acute medicine·2026
Same journal

Editorial - Differential attainment in training in the United Kingdom.

Acute medicine·2026
See all related articles

Related Experiment Video

Updated: Jun 1, 2026

Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo
10:19

Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo

Published on: March 31, 2016

Myxoedema coma.

B Turner1

  • 1Dept. of Diabetes and Endocrinology, E-Level, North Hampshire Hospital, Aldermaston Road, Basingstoke, Hants RG24 9LN.

Acute Medicine
|June 10, 2011
PubMed
Summary
This summary is machine-generated.

Myxoedema coma, a severe hypothyroidism complication, requires intensive care and prompt treatment. Early identification of hypercapnia, hyponatraemia, and sepsis is crucial for life-saving interventions.

More Related Videos

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion
03:37

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Published on: July 5, 2024

Related Experiment Videos

Last Updated: Jun 1, 2026

Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo
10:19

Induction of an Isoelectric Brain State to Investigate the Impact of Endogenous Synaptic Activity on Neuronal Excitability In Vivo

Published on: March 31, 2016

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion
03:37

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Published on: July 5, 2024

Area of Science:

  • Endocrinology
  • Critical Care Medicine

Background:

  • Myxoedema coma is a rare, severe manifestation of hypothyroidism.
  • It presents with multisystem decompensation and carries a poor prognosis.

Purpose of the Study:

  • To highlight the critical importance of prompt and careful management of myxoedema coma.
  • To emphasize key diagnostic and therapeutic considerations.

Main Methods:

  • Review of clinical presentation and management strategies for myxoedema coma.
  • Focus on early recognition of specific complications.

Main Results:

  • Multisystem decompensation is a hallmark of myxoedema coma.
  • Early identification of hypercapnia, hyponatraemia, and sepsis is vital.
  • Intravenous thyroid hormone and steroid cover are initial treatment components.

Conclusions:

  • Myxoedema coma demands high-dependency or intensive care.
  • Prompt initiation of treatment upon suspicion is life-saving.
  • Optimal intravenous thyroid hormone dosing requires further clarification.